Related Articles
Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma
Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy
Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma
Prognostic impact of interleukin‑6 and C‑reactive protein on patients with breast cancer